Hotline: +86-18022463983    020-85206863

Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Research Report 2026

Published Date: 2026-04-29   |   Pages: 133   |   Tables: 126   |  Medical Devices & Consumables

The global Next-Generation Sequencing, NGS Test Kits and Instruments market was valued at US$ 4685 million in 2025 and is anticipated to reach US$ 7892 million by 2032, at a CAGR of 8.0% from 2026 to 2032.
Next-Generation Sequencing (NGS) Test Kits and Instruments refer to integrated solutions that utilize high-throughput sequencing technologies, combining sample preparation reagents, library construction kits, sequencing consumables, and automated sequencing instruments to perform large-scale parallel analysis of DNA or RNA sequences. Centered on a “platform + consumables + data analysis” ecosystem, NGS enables the simultaneous decoding of millions to billions of sequences in a single run, significantly improving efficiency and accuracy. Its applications have rapidly expanded from research to clinical diagnostics, oncology precision medicine, genetic disease screening, and infectious disease surveillance, making it a critical infrastructure for advancing precision medicine and molecular diagnostics.The average gross profit margin of this product is 68%.
Driven by the rapid advancement of precision medicine and genomics, NGS test kits and instruments are emerging as a core growth engine in molecular diagnostics. Corporate reports and government initiatives indicate that expanding demand in oncology precision therapy, rare disease screening, and infectious disease control is accelerating clinical adoption. Increased public funding for genomics research and biotechnology further boosts market penetration. Technologically, declining sequencing costs, higher throughput, and improved automation are transforming NGS from a specialized research tool into a scalable clinical solution. Moreover, the integrated “instrument + consumables” model ensures recurring revenue streams, strengthening long-term profitability and customer retention. Despite strong growth momentum, the industry faces several structural challenges. High upfront costs of sequencing instruments create barriers for smaller laboratories and healthcare providers. In addition, complex workflows and the need for advanced bioinformatics capabilities limit adoption in less developed regions. The tight coupling between instruments and proprietary reagents, while beneficial for vendors, increases operational costs and dependency risks for users. Regulatory requirements for clinical applications are stringent, and variations across regions add complexity to global commercialization strategies. Downstream demand is shifting from research-driven applications toward widespread clinical and industrial use. Oncology genomics, companion diagnostics, and liquid biopsy represent high-growth segments, while genetic disease screening and newborn testing continue to expand. Public health needs have further highlighted the role of NGS in pathogen detection and epidemiological surveillance, positioning it as a critical component of disease monitoring systems. Meanwhile, pharmaceutical and biotechnology companies are increasingly leveraging NGS in drug discovery and biomarker identification, transforming it into a data-driven platform across the life sciences ecosystem. The upstream supply chain is centered on high-purity biochemical reagents and advanced manufacturing components, including enzymes, nucleotides, primers, probes, buffer systems, and sequencing chips. As sequencing performance requirements increase, greater emphasis is placed on consistency, stability, and batch control of raw materials. Consumables dominate the value chain, serving as the primary source of recurring revenue. Meanwhile, core instruments rely on sophisticated technologies such as optical detection systems, semiconductor chips, and microfluidics, creating high technological barriers. Upstream players are increasingly adopting integrated platform strategies, combining instruments with proprietary consumables to enhance competitiveness and customer lock-in.
This report delivers a comprehensive overview of the global Next-Generation Sequencing, NGS Test Kits and Instruments market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Next-Generation Sequencing, NGS Test Kits and Instruments. The Next-Generation Sequencing, NGS Test Kits and Instruments market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Next-Generation Sequencing, NGS Test Kits and Instruments market comprehensively. Regional market sizes by Type, by Application, by End Users, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Next-Generation Sequencing, NGS Test Kits and Instruments manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link
Agilent Technologies
Thermo Fisher Scientific
Bio-Rad Laboratories
QIAGEN
Segment by Type
Kit
Instruments
Segment by End Users
Hospitals
Reference Labs
Research Institutes
Other
Segment by Throughput Level
Ultra High Throughput
High Throughput
Medium Throughput
Low Throughput
Segment by Application
Oncology Testing
Genetic Screening
Infectious Disease
Research Use
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by End Users, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Next-Generation Sequencing, NGS Test Kits and Instruments companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


★Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

★Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

★Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

★Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Kit
1.2.3 Instruments
1.3 Market by End Users
1.3.1 Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Size Growth Rate by End Users: 2021 vs 2025 vs 2032
1.3.2 Hospitals
1.3.3 Reference Labs
1.3.4 Research Institutes
1.3.5 Other
1.4 Market by Throughput Level
1.4.1 Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Size Growth Rate by Throughput Level: 2021 vs 2025 vs 2032
1.4.2 Ultra High Throughput
1.4.3 High Throughput
1.4.4 Medium Throughput
1.4.5 Low Throughput
1.5 Market by Application
1.5.1 Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Oncology Testing
1.5.3 Genetic Screening
1.5.4 Infectious Disease
1.5.5 Research Use
1.5.6 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Perspective (2021–2032)
2.2 Global Next-Generation Sequencing, NGS Test Kits and Instruments Growth Trends by Region
2.2.1 Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Next-Generation Sequencing, NGS Test Kits and Instruments Historic Market Size by Region (2021–2026)
2.2.3 Next-Generation Sequencing, NGS Test Kits and Instruments Forecasted Market Size by Region (2027–2032)
2.3 Next-Generation Sequencing, NGS Test Kits and Instruments Market Dynamics
2.3.1 Next-Generation Sequencing, NGS Test Kits and Instruments Industry Trends
2.3.2 Next-Generation Sequencing, NGS Test Kits and Instruments Market Drivers
2.3.3 Next-Generation Sequencing, NGS Test Kits and Instruments Market Challenges
2.3.4 Next-Generation Sequencing, NGS Test Kits and Instruments Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next-Generation Sequencing, NGS Test Kits and Instruments Players by Revenue
3.1.1 Global Top Next-Generation Sequencing, NGS Test Kits and Instruments Players by Revenue (2021–2026)
3.1.2 Global Next-Generation Sequencing, NGS Test Kits and Instruments Revenue Market Share by Players (2021–2026)
3.2 Global Top Next-Generation Sequencing, NGS Test Kits and Instruments Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Next-Generation Sequencing, NGS Test Kits and Instruments Revenue
3.4 Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Concentration Ratio
3.4.1 Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next-Generation Sequencing, NGS Test Kits and Instruments Revenue in 2025
3.5 Global Key Players of Next-Generation Sequencing, NGS Test Kits and Instruments Head Offices and Areas Served
3.6 Global Key Players of Next-Generation Sequencing, NGS Test Kits and Instruments, Products and Applications
3.7 Global Key Players of Next-Generation Sequencing, NGS Test Kits and Instruments, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Next-Generation Sequencing, NGS Test Kits and Instruments Breakdown Data by Type
4.1 Global Next-Generation Sequencing, NGS Test Kits and Instruments Historic Market Size by Type (2021–2026)
4.2 Global Next-Generation Sequencing, NGS Test Kits and Instruments Forecasted Market Size by Type (2027–2032)
5 Next-Generation Sequencing, NGS Test Kits and Instruments Breakdown Data by Application
5.1 Global Next-Generation Sequencing, NGS Test Kits and Instruments Historic Market Size by Application (2021–2026)
5.2 Global Next-Generation Sequencing, NGS Test Kits and Instruments Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Next-Generation Sequencing, NGS Test Kits and Instruments Market Size (2021–2032)
6.2 North America Next-Generation Sequencing, NGS Test Kits and Instruments Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Next-Generation Sequencing, NGS Test Kits and Instruments Market Size by Country (2021–2026)
6.4 North America Next-Generation Sequencing, NGS Test Kits and Instruments Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Next-Generation Sequencing, NGS Test Kits and Instruments Market Size (2021–2032)
7.2 Europe Next-Generation Sequencing, NGS Test Kits and Instruments Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Next-Generation Sequencing, NGS Test Kits and Instruments Market Size by Country (2021–2026)
7.4 Europe Next-Generation Sequencing, NGS Test Kits and Instruments Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Next-Generation Sequencing, NGS Test Kits and Instruments Market Size (2021–2032)
8.2 Asia-Pacific Next-Generation Sequencing, NGS Test Kits and Instruments Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Next-Generation Sequencing, NGS Test Kits and Instruments Market Size by Region (2021–2026)
8.4 Asia-Pacific Next-Generation Sequencing, NGS Test Kits and Instruments Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Next-Generation Sequencing, NGS Test Kits and Instruments Market Size (2021–2032)
9.2 Latin America Next-Generation Sequencing, NGS Test Kits and Instruments Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Next-Generation Sequencing, NGS Test Kits and Instruments Market Size by Country (2021–2026)
9.4 Latin America Next-Generation Sequencing, NGS Test Kits and Instruments Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next-Generation Sequencing, NGS Test Kits and Instruments Market Size (2021–2032)
10.2 Middle East & Africa Next-Generation Sequencing, NGS Test Kits and Instruments Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Next-Generation Sequencing, NGS Test Kits and Instruments Market Size by Country (2021–2026)
10.4 Middle East & Africa Next-Generation Sequencing, NGS Test Kits and Instruments Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Details
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific Next-Generation Sequencing, NGS Test Kits and Instruments Introduction
11.1.4 Eurofins Scientific Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
11.1.5 Eurofins Scientific Recent Development
11.2 Natera
11.2.1 Natera Company Details
11.2.2 Natera Business Overview
11.2.3 Natera Next-Generation Sequencing, NGS Test Kits and Instruments Introduction
11.2.4 Natera Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
11.2.5 Natera Recent Development
11.3 BGI
11.3.1 BGI Company Details
11.3.2 BGI Business Overview
11.3.3 BGI Next-Generation Sequencing, NGS Test Kits and Instruments Introduction
11.3.4 BGI Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
11.3.5 BGI Recent Development
11.4 Illumina
11.4.1 Illumina Company Details
11.4.2 Illumina Business Overview
11.4.3 Illumina Next-Generation Sequencing, NGS Test Kits and Instruments Introduction
11.4.4 Illumina Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
11.4.5 Illumina Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Next-Generation Sequencing, NGS Test Kits and Instruments Introduction
11.5.4 Roche Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
11.5.5 Roche Recent Development
11.6 LabCorp
11.6.1 LabCorp Company Details
11.6.2 LabCorp Business Overview
11.6.3 LabCorp Next-Generation Sequencing, NGS Test Kits and Instruments Introduction
11.6.4 LabCorp Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
11.6.5 LabCorp Recent Development
11.7 Berry Genomics
11.7.1 Berry Genomics Company Details
11.7.2 Berry Genomics Business Overview
11.7.3 Berry Genomics Next-Generation Sequencing, NGS Test Kits and Instruments Introduction
11.7.4 Berry Genomics Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
11.7.5 Berry Genomics Recent Development
11.8 Brooks Life Sciences
11.8.1 Brooks Life Sciences Company Details
11.8.2 Brooks Life Sciences Business Overview
11.8.3 Brooks Life Sciences Next-Generation Sequencing, NGS Test Kits and Instruments Introduction
11.8.4 Brooks Life Sciences Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
11.8.5 Brooks Life Sciences Recent Development
11.9 Macrogen
11.9.1 Macrogen Company Details
11.9.2 Macrogen Business Overview
11.9.3 Macrogen Next-Generation Sequencing, NGS Test Kits and Instruments Introduction
11.9.4 Macrogen Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
11.9.5 Macrogen Recent Development
11.10 Personalis
11.10.1 Personalis Company Details
11.10.2 Personalis Business Overview
11.10.3 Personalis Next-Generation Sequencing, NGS Test Kits and Instruments Introduction
11.10.4 Personalis Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
11.10.5 Personalis Recent Development
11.11 Novogene
11.11.1 Novogene Company Details
11.11.2 Novogene Business Overview
11.11.3 Novogene Next-Generation Sequencing, NGS Test Kits and Instruments Introduction
11.11.4 Novogene Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
11.11.5 Novogene Recent Development
11.12 Genotypic Technology
11.12.1 Genotypic Technology Company Details
11.12.2 Genotypic Technology Business Overview
11.12.3 Genotypic Technology Next-Generation Sequencing, NGS Test Kits and Instruments Introduction
11.12.4 Genotypic Technology Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
11.12.5 Genotypic Technology Recent Development
11.13 Dna Link
11.13.1 Dna Link Company Details
11.13.2 Dna Link Business Overview
11.13.3 Dna Link Next-Generation Sequencing, NGS Test Kits and Instruments Introduction
11.13.4 Dna Link Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
11.13.5 Dna Link Recent Development
11.14 Agilent Technologies
11.14.1 Agilent Technologies Company Details
11.14.2 Agilent Technologies Business Overview
11.14.3 Agilent Technologies Next-Generation Sequencing, NGS Test Kits and Instruments Introduction
11.14.4 Agilent Technologies Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
11.14.5 Agilent Technologies Recent Development
11.15 Thermo Fisher Scientific
11.15.1 Thermo Fisher Scientific Company Details
11.15.2 Thermo Fisher Scientific Business Overview
11.15.3 Thermo Fisher Scientific Next-Generation Sequencing, NGS Test Kits and Instruments Introduction
11.15.4 Thermo Fisher Scientific Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
11.15.5 Thermo Fisher Scientific Recent Development
11.16 Bio-Rad Laboratories
11.16.1 Bio-Rad Laboratories Company Details
11.16.2 Bio-Rad Laboratories Business Overview
11.16.3 Bio-Rad Laboratories Next-Generation Sequencing, NGS Test Kits and Instruments Introduction
11.16.4 Bio-Rad Laboratories Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
11.16.5 Bio-Rad Laboratories Recent Development
11.17 QIAGEN
11.17.1 QIAGEN Company Details
11.17.2 QIAGEN Business Overview
11.17.3 QIAGEN Next-Generation Sequencing, NGS Test Kits and Instruments Introduction
11.17.4 QIAGEN Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
11.17.5 QIAGEN Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Kit
Table 3. Key Players of Instruments
Table 4. Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Size Growth Rate by End Users (US$ Million): 2021 vs 2025 vs 2032
Table 5. Key Players of Hospitals
Table 6. Key Players of Reference Labs
Table 7. Key Players of Research Institutes
Table 8. Key Players of Other
Table 9. Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Size Growth Rate by Throughput Level (US$ Million): 2021 vs 2025 vs 2032
Table 10. Key Players of Ultra High Throughput
Table 11. Key Players of High Throughput
Table 12. Key Players of Medium Throughput
Table 13. Key Players of Low Throughput
Table 14. Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 15. Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 16. Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Size by Region (US$ Million), 2021–2026
Table 17. Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Share by Region (2021–2026)
Table 18. Global Next-Generation Sequencing, NGS Test Kits and Instruments Forecasted Market Size by Region (US$ Million), 2027–2032
Table 19. Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Share by Region (2027–2032)
Table 20. Next-Generation Sequencing, NGS Test Kits and Instruments Market Trends
Table 21. Next-Generation Sequencing, NGS Test Kits and Instruments Market Drivers
Table 22. Next-Generation Sequencing, NGS Test Kits and Instruments Market Challenges
Table 23. Next-Generation Sequencing, NGS Test Kits and Instruments Market Restraints
Table 24. Global Next-Generation Sequencing, NGS Test Kits and Instruments Revenue by Players (US$ Million), 2021–2026
Table 25. Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Share by Players (2021–2026)
Table 26. Global Top Next-Generation Sequencing, NGS Test Kits and Instruments Players by Tier (Tier 1, Tier 2, and Tier 3), based on Next-Generation Sequencing, NGS Test Kits and Instruments Revenue, 2025
Table 27. Ranking of Global Top Next-Generation Sequencing, NGS Test Kits and Instruments Companies by Revenue (US$ Million) in 2025
Table 28. Global 5 Largest Players Market Share by Next-Generation Sequencing, NGS Test Kits and Instruments Revenue (CR5 and HHI), 2021–2026
Table 29. Global Key Players of Next-Generation Sequencing, NGS Test Kits and Instruments, Headquarters and Area Served
Table 30. Global Key Players of Next-Generation Sequencing, NGS Test Kits and Instruments, Products and Applications
Table 31. Global Key Players of Next-Generation Sequencing, NGS Test Kits and Instruments, Date of General Availability (GA)
Table 32. Mergers and Acquisitions, Expansion Plans
Table 33. Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Size by Type (US$ Million), 2021–2026
Table 34. Global Next-Generation Sequencing, NGS Test Kits and Instruments Revenue Market Share by Type (2021–2026)
Table 35. Global Next-Generation Sequencing, NGS Test Kits and Instruments Forecasted Market Size by Type (US$ Million), 2027–2032
Table 36. Global Next-Generation Sequencing, NGS Test Kits and Instruments Revenue Market Share by Type (2027–2032)
Table 37. Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Size by Application (US$ Million), 2021–2026
Table 38. Global Next-Generation Sequencing, NGS Test Kits and Instruments Revenue Market Share by Application (2021–2026)
Table 39. Global Next-Generation Sequencing, NGS Test Kits and Instruments Forecasted Market Size by Application (US$ Million), 2027–2032
Table 40. Global Next-Generation Sequencing, NGS Test Kits and Instruments Revenue Market Share by Application (2027–2032)
Table 41. North America Next-Generation Sequencing, NGS Test Kits and Instruments Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. North America Next-Generation Sequencing, NGS Test Kits and Instruments Market Size by Country (US$ Million), 2021–2026
Table 43. North America Next-Generation Sequencing, NGS Test Kits and Instruments Market Size by Country (US$ Million), 2027–2032
Table 44. Europe Next-Generation Sequencing, NGS Test Kits and Instruments Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Europe Next-Generation Sequencing, NGS Test Kits and Instruments Market Size by Country (US$ Million), 2021–2026
Table 46. Europe Next-Generation Sequencing, NGS Test Kits and Instruments Market Size by Country (US$ Million), 2027–2032
Table 47. Asia-Pacific Next-Generation Sequencing, NGS Test Kits and Instruments Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 48. Asia-Pacific Next-Generation Sequencing, NGS Test Kits and Instruments Market Size by Region (US$ Million), 2021–2026
Table 49. Asia-Pacific Next-Generation Sequencing, NGS Test Kits and Instruments Market Size by Region (US$ Million), 2027–2032
Table 50. Latin America Next-Generation Sequencing, NGS Test Kits and Instruments Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 51. Latin America Next-Generation Sequencing, NGS Test Kits and Instruments Market Size by Country (US$ Million), 2021–2026
Table 52. Latin America Next-Generation Sequencing, NGS Test Kits and Instruments Market Size by Country (US$ Million), 2027–2032
Table 53. Middle East & Africa Next-Generation Sequencing, NGS Test Kits and Instruments Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 54. Middle East & Africa Next-Generation Sequencing, NGS Test Kits and Instruments Market Size by Country (US$ Million), 2021–2026
Table 55. Middle East & Africa Next-Generation Sequencing, NGS Test Kits and Instruments Market Size by Country (US$ Million), 2027–2032
Table 56. Eurofins Scientific Company Details
Table 57. Eurofins Scientific Business Overview
Table 58. Eurofins Scientific Next-Generation Sequencing, NGS Test Kits and Instruments Product
Table 59. Eurofins Scientific Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (US$ Million), 2021–2026
Table 60. Eurofins Scientific Recent Development
Table 61. Natera Company Details
Table 62. Natera Business Overview
Table 63. Natera Next-Generation Sequencing, NGS Test Kits and Instruments Product
Table 64. Natera Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (US$ Million), 2021–2026
Table 65. Natera Recent Development
Table 66. BGI Company Details
Table 67. BGI Business Overview
Table 68. BGI Next-Generation Sequencing, NGS Test Kits and Instruments Product
Table 69. BGI Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (US$ Million), 2021–2026
Table 70. BGI Recent Development
Table 71. Illumina Company Details
Table 72. Illumina Business Overview
Table 73. Illumina Next-Generation Sequencing, NGS Test Kits and Instruments Product
Table 74. Illumina Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (US$ Million), 2021–2026
Table 75. Illumina Recent Development
Table 76. Roche Company Details
Table 77. Roche Business Overview
Table 78. Roche Next-Generation Sequencing, NGS Test Kits and Instruments Product
Table 79. Roche Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (US$ Million), 2021–2026
Table 80. Roche Recent Development
Table 81. LabCorp Company Details
Table 82. LabCorp Business Overview
Table 83. LabCorp Next-Generation Sequencing, NGS Test Kits and Instruments Product
Table 84. LabCorp Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (US$ Million), 2021–2026
Table 85. LabCorp Recent Development
Table 86. Berry Genomics Company Details
Table 87. Berry Genomics Business Overview
Table 88. Berry Genomics Next-Generation Sequencing, NGS Test Kits and Instruments Product
Table 89. Berry Genomics Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (US$ Million), 2021–2026
Table 90. Berry Genomics Recent Development
Table 91. Brooks Life Sciences Company Details
Table 92. Brooks Life Sciences Business Overview
Table 93. Brooks Life Sciences Next-Generation Sequencing, NGS Test Kits and Instruments Product
Table 94. Brooks Life Sciences Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (US$ Million), 2021–2026
Table 95. Brooks Life Sciences Recent Development
Table 96. Macrogen Company Details
Table 97. Macrogen Business Overview
Table 98. Macrogen Next-Generation Sequencing, NGS Test Kits and Instruments Product
Table 99. Macrogen Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (US$ Million), 2021–2026
Table 100. Macrogen Recent Development
Table 101. Personalis Company Details
Table 102. Personalis Business Overview
Table 103. Personalis Next-Generation Sequencing, NGS Test Kits and Instruments Product
Table 104. Personalis Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (US$ Million), 2021–2026
Table 105. Personalis Recent Development
Table 106. Novogene Company Details
Table 107. Novogene Business Overview
Table 108. Novogene Next-Generation Sequencing, NGS Test Kits and Instruments Product
Table 109. Novogene Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (US$ Million), 2021–2026
Table 110. Novogene Recent Development
Table 111. Genotypic Technology Company Details
Table 112. Genotypic Technology Business Overview
Table 113. Genotypic Technology Next-Generation Sequencing, NGS Test Kits and Instruments Product
Table 114. Genotypic Technology Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (US$ Million), 2021–2026
Table 115. Genotypic Technology Recent Development
Table 116. Dna Link Company Details
Table 117. Dna Link Business Overview
Table 118. Dna Link Next-Generation Sequencing, NGS Test Kits and Instruments Product
Table 119. Dna Link Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (US$ Million), 2021–2026
Table 120. Dna Link Recent Development
Table 121. Agilent Technologies Company Details
Table 122. Agilent Technologies Business Overview
Table 123. Agilent Technologies Next-Generation Sequencing, NGS Test Kits and Instruments Product
Table 124. Agilent Technologies Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (US$ Million), 2021–2026
Table 125. Agilent Technologies Recent Development
Table 126. Thermo Fisher Scientific Company Details
Table 127. Thermo Fisher Scientific Business Overview
Table 128. Thermo Fisher Scientific Next-Generation Sequencing, NGS Test Kits and Instruments Product
Table 129. Thermo Fisher Scientific Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (US$ Million), 2021–2026
Table 130. Thermo Fisher Scientific Recent Development
Table 131. Bio-Rad Laboratories Company Details
Table 132. Bio-Rad Laboratories Business Overview
Table 133. Bio-Rad Laboratories Next-Generation Sequencing, NGS Test Kits and Instruments Product
Table 134. Bio-Rad Laboratories Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (US$ Million), 2021–2026
Table 135. Bio-Rad Laboratories Recent Development
Table 136. QIAGEN Company Details
Table 137. QIAGEN Business Overview
Table 138. QIAGEN Next-Generation Sequencing, NGS Test Kits and Instruments Product
Table 139. QIAGEN Revenue in Next-Generation Sequencing, NGS Test Kits and Instruments Business (US$ Million), 2021–2026
Table 140. QIAGEN Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
Table 144. Authors List of This Report


List of Figures
Figure 1. Next-Generation Sequencing, NGS Test Kits and Instruments Picture
Figure 2. Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Share by Type: 2025 vs 2032
Figure 4. Kit Features
Figure 5. Instruments Features
Figure 6. Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Size Comparison by End Users (US$ Million), 2021–2032
Figure 7. Hospitals Features
Figure 8. Reference Labs Features
Figure 9. Research Institutes Features
Figure 10. Other Features
Figure 11. Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Size Comparison by Throughput Level (US$ Million), 2021–2032
Figure 12. Ultra High Throughput Features
Figure 13. High Throughput Features
Figure 14. Medium Throughput Features
Figure 15. Low Throughput Features
Figure 16. Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Size by Application (US$ Million), 2021–2032
Figure 17. Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Share by Application: 2025 vs 2032
Figure 18. Oncology Testing Case Studies
Figure 19. Genetic Screening Case Studies
Figure 20. Infectious Disease Case Studies
Figure 21. Research Use Case Studies
Figure 22. Other Case Studies
Figure 23. Next-Generation Sequencing, NGS Test Kits and Instruments Report Years Considered
Figure 24. Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 25. Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 26. Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Share by Region: 2025 vs 2032
Figure 27. Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Share by Players in 2025
Figure 28. Global Next-Generation Sequencing, NGS Test Kits and Instruments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 29. The Top 10 and 5 Players Market Share by Next-Generation Sequencing, NGS Test Kits and Instruments Revenue in 2025
Figure 30. North America Next-Generation Sequencing, NGS Test Kits and Instruments Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. North America Next-Generation Sequencing, NGS Test Kits and Instruments Market Share by Country (2021–2032)
Figure 32. United States Next-Generation Sequencing, NGS Test Kits and Instruments Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Canada Next-Generation Sequencing, NGS Test Kits and Instruments Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Europe Next-Generation Sequencing, NGS Test Kits and Instruments Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Europe Next-Generation Sequencing, NGS Test Kits and Instruments Market Share by Country (2021–2032)
Figure 36. Germany Next-Generation Sequencing, NGS Test Kits and Instruments Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. France Next-Generation Sequencing, NGS Test Kits and Instruments Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. U.K. Next-Generation Sequencing, NGS Test Kits and Instruments Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Italy Next-Generation Sequencing, NGS Test Kits and Instruments Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Russia Next-Generation Sequencing, NGS Test Kits and Instruments Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Ireland Next-Generation Sequencing, NGS Test Kits and Instruments Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Asia-Pacific Next-Generation Sequencing, NGS Test Kits and Instruments Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Asia-Pacific Next-Generation Sequencing, NGS Test Kits and Instruments Market Share by Region (2021–2032)
Figure 44. China Next-Generation Sequencing, NGS Test Kits and Instruments Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Japan Next-Generation Sequencing, NGS Test Kits and Instruments Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. South Korea Next-Generation Sequencing, NGS Test Kits and Instruments Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Southeast Asia Next-Generation Sequencing, NGS Test Kits and Instruments Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. India Next-Generation Sequencing, NGS Test Kits and Instruments Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Australia & New Zealand Next-Generation Sequencing, NGS Test Kits and Instruments Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Latin America Next-Generation Sequencing, NGS Test Kits and Instruments Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Latin America Next-Generation Sequencing, NGS Test Kits and Instruments Market Share by Country (2021–2032)
Figure 52. Mexico Next-Generation Sequencing, NGS Test Kits and Instruments Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. Brazil Next-Generation Sequencing, NGS Test Kits and Instruments Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. Middle East & Africa Next-Generation Sequencing, NGS Test Kits and Instruments Market Size YoY Growth (US$ Million), 2021–2032
Figure 55. Middle East & Africa Next-Generation Sequencing, NGS Test Kits and Instruments Market Share by Country (2021–2032)
Figure 56. Israel Next-Generation Sequencing, NGS Test Kits and Instruments Market Size YoY Growth (US$ Million), 2021–2032
Figure 57. Saudi Arabia Next-Generation Sequencing, NGS Test Kits and Instruments Market Size YoY Growth (US$ Million), 2021–2032
Figure 58. UAE Next-Generation Sequencing, NGS Test Kits and Instruments Market Size YoY Growth (US$ Million), 2021–2032
Figure 59. Eurofins Scientific Revenue Growth Rate in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
Figure 60. Natera Revenue Growth Rate in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
Figure 61. BGI Revenue Growth Rate in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
Figure 62. Illumina Revenue Growth Rate in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
Figure 63. Roche Revenue Growth Rate in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
Figure 64. LabCorp Revenue Growth Rate in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
Figure 65. Berry Genomics Revenue Growth Rate in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
Figure 66. Brooks Life Sciences Revenue Growth Rate in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
Figure 67. Macrogen Revenue Growth Rate in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
Figure 68. Personalis Revenue Growth Rate in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
Figure 69. Novogene Revenue Growth Rate in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
Figure 70. Genotypic Technology Revenue Growth Rate in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
Figure 71. Dna Link Revenue Growth Rate in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
Figure 72. Agilent Technologies Revenue Growth Rate in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
Figure 73. Thermo Fisher Scientific Revenue Growth Rate in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
Figure 74. Bio-Rad Laboratories Revenue Growth Rate in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
Figure 75. QIAGEN Revenue Growth Rate in Next-Generation Sequencing, NGS Test Kits and Instruments Business (2021–2026)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

Our Clients